BRMS1: a Multifunctional Signaling Molecule in Metastasis
Overview
Authors
Affiliations
Despite high mortality rates, molecular understanding of metastasis remains limited. It can be regulated by both pro- and anti-metastasis genes. The metastasis suppressor, breast cancer metastasis suppressor 1 (BRMS1), has been positively correlated with patient outcomes, but molecular functions are still being characterized. BRMS1 has been implicated in focal adhesion kinase (FAK), epidermal growth factor receptor (EGFR), and NF-κB signaling pathways. We review evidence that BRMS1 regulates these vast signaling pathways through chromatin remodeling as a member of mSin3 histone deacetylase complexes.
Metastasis suppressor genes and their role in the tumor microenvironment.
Megino-Luque C, Bravo-Cordero J Cancer Metastasis Rev. 2023; 42(4):1147-1154.
PMID: 37982987 PMC: 10842895. DOI: 10.1007/s10555-023-10155-6.
Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer.
Supuramanian S, Dsa S, Harihar S Explor Target Antitumor Ther. 2023; 4(5):912-932.
PMID: 37970212 PMC: 10645471. DOI: 10.37349/etat.2023.00173.
Metastasis suppressor genes in clinical practice: are they druggable?.
Gelman I Cancer Metastasis Rev. 2023; 42(4):1169-1188.
PMID: 37749308 PMC: 11629483. DOI: 10.1007/s10555-023-10135-w.
BRMS1 in Gliomas-An Expression Analysis.
Feldheim J, Kessler A, Feldheim J, Schmitt D, Oster C, Lazaridis L Cancers (Basel). 2023; 15(11).
PMID: 37296870 PMC: 10252102. DOI: 10.3390/cancers15112907.
Qin X, Yi S, Rong J, Lu H, Ji B, Zhang W Front Aging Neurosci. 2023; 15:1142163.
PMID: 37032832 PMC: 10076550. DOI: 10.3389/fnagi.2023.1142163.